The results of this study suggest the potential value of tumor CXCL12 expression as a marker to predict prognosis and to indicate adjuvant chemotherapy in NSCLC patients that underwent surgical tumor resection. This evidence concerns the gene CXCL12 and non-small cell lung carcinoma.